PDF herunterladen
Semin Plast Surg 2013; 27(01): 013-018
DOI: 10.1055/s-0033-1343990
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Preventive Care and Evaluation of the Adolescent with a Breast Mass

Yasmin Jayasinghe
1   Department of Gynaecology, Royal Children's Hospital, Victoria, Australia
2   Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Victoria, Australia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. Mai 2013 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Adolescents have little knowledge of preventive breast care or breast screening, yet exposures in youth influence the risk of future breast disease.Nipple piercing increases the risk of trauma and breast infection. Alcohol consumption, smoking, nutrition, obesity, reproductive factors, previous cancer and chest radiotherapy, family history of breast cancer or genetic mutation increase the risk of breast cancer. Breast cancer is rare in adolescents and currently genetic testing is not recommended in those under 18 years, as medical surveillance is not usually recommended until around 25 years. Screening measures include clinical breast exam every 1 to 3 years, and breast self-awareness in healthy women from 20 years; and at least annual breast self examination, with annual clinical breast examination, mammography and magnetic resonance imaging in high-risk patients from 25 years. Breast ultrasound is used in diagnostic evaluation of breast masses in adolescents as mammography is less sensitive in young women.

Keywords

adolescent - breast cancer - breast screening - BRCA1/2 - body piercing
 

  • References

  • 1 Byrne C, Webb PM, Jacobs TW , et al. Alcohol consumption and incidence of benign breast disease. Cancer Epidemiol Biomarkers Prev 2002; 11 (11) 1369-1374
    PubMedGoogle Scholar
  • 2 Quaranta A, Napoli C, Fasano F, Montagna C, Caggiano G, Montagna MT. Body piercing and tattoos: a survey on young adults' knowledge of the risks and practices in body art. BMC Public Health 2011; 11: 774-782
    CrossrefPubMedGoogle Scholar
  • 3 Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 1995; 4 (5) 567-571
    PubMedGoogle Scholar
  • 4 Jayasinghe Y, Simmons P. Disorders of the young breast. In: Altchek A, Deligdisch L, , eds. Pediatric, Adolescent and Young Adult Gynecology. Oxford, UK: Wiley-Blackwell; 2009. : 256-264
    CrossrefGoogle Scholar
  • 5 Simmons P, Wold L. Surgically treated breast disease in adolescent females: a retrospective review of 185 cases. Adolesc Pediatr Gynecol 1989; 2: 95-98
    PubMedGoogle Scholar
  • 6 Simmons PS, Jayasinghe YL, Wold LE, Melton III LJ. Breast carcinoma in young women. Obstet Gynecol 2011; 118 (3) 529-536
    CrossrefPubMedGoogle Scholar
  • 7 American Cancer Society. Breast cancer facts & figures: 2011–2012. Atlanta, GA: American Cancer Society;
    Google Scholar
  • 8 Early J, Armstrong SN, Burke S, Thompson DL. US female college students' breast health knowledge, attitudes, and determinants of screening practices: new implications for health education. J Am Coll Health 2011; 59 (7) 640-647
    CrossrefPubMedGoogle Scholar
  • 9 Hartmann LC, Sellers TA, Frost MH , et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005; 353 (3) 229-237
    CrossrefPubMedGoogle Scholar
  • 10 Sangaramoorthy M, Phipps AI, Horn-Ross PL, Koo J, John EM. Early-life factors and breast cancer risk in Hispanic women: the role of adolescent body size. Cancer Epidemiol Biomarkers Prev 2011; 20 (12) 2572-2582
    CrossrefPubMedGoogle Scholar
  • 11 Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347 (9017) 1713-1727
    CrossrefPubMedGoogle Scholar
  • 12 Kahlenborn C, Modugno FS, Potter DM, Severs WB. Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clin Proc 2006; 81 (10) 1290-1302
    CrossrefPubMedGoogle Scholar
  • 13 Al-Delaimy WK, Cho E, Chen WY, Colditz G, Willet WC. A prospective study of smoking and risk of breast cancer in young adult women. Cancer Epidemiol Biomarkers Prev 2004; 13 (3) 398-404
    PubMedGoogle Scholar
  • 14 Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents—DNA adducts and mutations. J Natl Cancer Inst Monogr 2000; 27 (27) 75-93
    PubMedGoogle Scholar
  • 15 Gollapalli V, Liao J, Dudakovic A, Sugg SL, Scott-Conner CE, Weigel RJ. Risk factors for development and recurrence of primary breast abscesses. J Am Coll Surg 2010; 211 (1) 41-48
    CrossrefPubMedGoogle Scholar
  • 16 Garland M, Hunter DJ, Colditz GA , et al. Alcohol consumption in relation to breast cancer risk in a cohort of United States women 25-42 years of age. Cancer Epidemiol Biomarkers Prev 1999; 8 (11) 1017-1021
    PubMedGoogle Scholar
  • 17 Berkey CS, Tamimi RM, Rosner B, Frazier AL, Colditz GA. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer 2012; 118 (11) 2796-2803
    CrossrefPubMedGoogle Scholar
  • 18 Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 2010; 121 (2) 469-477
    CrossrefPubMedGoogle Scholar
  • 19 Su X, Colditz GA, Collins LC , et al. Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease. Breast Cancer Res Treat 2012; 134 (2) 783-791
    CrossrefPubMedGoogle Scholar
  • 20 White KK, Park SY, Kolonel LN, Henderson BE, Wilkens LR. Body size and breast cancer risk: the Multiethnic Cohort. Int J Cancer 2012; 131 (5) E705-E716
    CrossrefPubMedGoogle Scholar
  • 21 Friedenreich CM, Cust AE. Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 2008; 42 (8) 636-647
    CrossrefPubMedGoogle Scholar
  • 22 Linos E, Willett WC, Cho E, Frazier L. Adolescent diet in relation to breast cancer risk among premenopausal women. Cancer Epidemiol Biomarkers Prev 2010; 19 (3) 689-696
    CrossrefPubMedGoogle Scholar
  • 23 Bardia A, Vachon CM, Olson JE , et al. Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17 (2) 374-378
    CrossrefPubMedGoogle Scholar
  • 24 Kenney LB, Yasui Y, Inskip PD , et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004; 141 (8) 590-597
    CrossrefPubMedGoogle Scholar
  • 25 King MC, Marks JH, Mandell JB. New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302 (5645) 643-646
    CrossrefPubMedGoogle Scholar
  • 26 Herman JD, Appelbaum H. Hereditary breast and ovarian cancer syndrome and issues in pediatric and adolescent practice. J Pediatr Adolesc Gynecol 2010; 23 (4) 253-258
    CrossrefPubMedGoogle Scholar
  • 27 American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins–Gynecology; ACOG Committee on Genetics; Society of Gynecologic Oncologists. ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstet Gynecol 2009; 113 (4) 957-966
    PubMedGoogle Scholar
  • 28 Walsh T, Casadei S, Coats KH , et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 2006; 295 (12) 1379-1388
    CrossrefPubMedGoogle Scholar
  • 29 Whittemore AS, Gong G, Itnyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 1997; 60 (3) 496-504
    PubMedGoogle Scholar
  • 30 Struewing JP, Hartge P, Wacholder S , et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336 (20) 1401-1408
    CrossrefPubMedGoogle Scholar
  • 31 Malone KE, Daling JR, Doody DR , et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 2006; 66 (16) 8297-8308
    CrossrefPubMedGoogle Scholar
  • 32 Bonadona V, Sinilnikova OM, Chopin S , et al. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France. Genes Chromosomes Cancer 2005; 43 (4) 404-413
    CrossrefPubMedGoogle Scholar
  • 33 Turnbull C, Rahman N. Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet 2008; 9: 321-345
    CrossrefPubMedGoogle Scholar
  • 34 Antoniou A, Pharoah PD, Narod S , et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72 (5) 1117-1130
    CrossrefPubMedGoogle Scholar
  • 35 Ford D, Easton DF, Stratton M , et al; The Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998; 62 (3) 676-689
    CrossrefPubMedGoogle Scholar
  • 36 Iodice S, Barile M, Rotmensz N , et al. Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis. Eur J Cancer 2010; 46 (12) 2275-2284
    CrossrefPubMedGoogle Scholar
  • 37 Narod SA, Dubé MP, Klijn J , et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2002; 94 (23) 1773-1779
    CrossrefPubMedGoogle Scholar
  • 38 U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005; 143 (5) 355-361
    CrossrefPubMedGoogle Scholar
  • 39 National Comprehensive Cancer Network Clinical Practive Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian Version 1. Fort Washington, PA: National Comprehensive Cancer Network; 2012
    Google Scholar
  • 40 American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003; 21 (12) 2397-2406
    CrossrefPubMedGoogle Scholar
  • 41 American Medical Association. Council on Ethical and Judicial Affairs: testing children for genetic status. CEJA Report 4–A-95. Chicago, IL: American Medical Association; 1995
    Google Scholar
  • 42 The National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Breast Cancer Screening and Diagnosis, Version 1. Fort Washington, PA: National Comprehensive Cancer Network; 2012
    Google Scholar
  • 43 Magnusson S, Borg A, Kristoffersson U, Nilbert M, Wiebe T, Olsson H. Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes. Fam Cancer 2008; 7 (4) 331-337
    CrossrefPubMedGoogle Scholar
  • 44 Howlett NG, Taniguchi T, Olson S , et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297 (5581) 606-609
    CrossrefPubMedGoogle Scholar
  • 45 Bradbury AR, Patrick-Miller L, Egleston BL , et al. When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response. Cancer 2012; 118 (13) 3417-3425
    CrossrefPubMedGoogle Scholar
  • 46 Elger BS, Harding TW. Testing adolescents for a hereditary breast cancer gene (BRCA1): respecting their autonomy is in their best interest. Arch Pediatr Adolesc Med 2000; 154 (2) 113-119
    CrossrefPubMedGoogle Scholar
  • 47 Bradbury AR, Patrick-Miller L, Egleston B , et al. Parent opinions regarding the genetic testing of minors for BRCA1/2. J Clin Oncol 2010; 28 (21) 3498-3505
    CrossrefPubMedGoogle Scholar
  • 48 Bradbury AR, Patrick-Miller L, Pawlowski K , et al. Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring. Am J Med Genet C Semin Med Genet 2008; 148C (1) 70-77
    CrossrefPubMedGoogle Scholar
  • 49 van der Meer LB, van Duijn E, Wolterbeek R, Tibben A. Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer. Clin Genet 2012; 81 (1) 18-23
    CrossrefPubMedGoogle Scholar
  • 50 Tercyak KP, Peshkin BN, Streisand R, Lerman C. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants. Psychooncology 2001; 10 (4) 336-346
    PubMedGoogle Scholar
  • 51 American College of Obstetricians-Gynecologists. Practice bulletin no. 122: breast cancer screening. Obstet Gynecol 2011; 118 (2 Pt 1) 372-382
    CrossrefPubMedGoogle Scholar
  • 52 Thomas DB, Gao DL, Ray RM , et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002; 94 (19) 1445-1457
    CrossrefPubMedGoogle Scholar
  • 53 Semiglazov VF, Sagaidak VN, Moiseyenko VM, Mikhailov EA. Study of the role of breast self-examination in the reduction of mortality from breast cancer. The Russian Federation/World Health Organization Study. Eur J Cancer 1993; 29A (14) 2039-2046
    PubMedGoogle Scholar
  • 54 Kösters JP, Gøtzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev 2003; (2) CD003373
    PubMedGoogle Scholar
  • 55 Bobo JK, Lee NC, Thames SF. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst 2000; 92 (12) 971-976
    CrossrefPubMedGoogle Scholar
  • 56 Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151 (10) 727-737 , W237-42
    CrossrefPubMedGoogle Scholar
  • 57 Pisano ED, Gatsonis C, Hendrick E , et al; Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group. Diagnostic performance of digital versus film mammography for breast-cancer screening. [published erratum in N Engl J Med 2006;355:1840] N Engl J Med 2005; 353 (17) 1773-1783
    CrossrefPubMedGoogle Scholar
  • 58 National Cancer Institute.. Breast cancer risk assessment tool. Available at www.cancer.gov/bcrisktool . Accessed September 12, 2012
    PubMedGoogle Scholar
  • 59 Sardanelli F, Podo F, Santoro F , et al; High Breast Cancer Risk Italian 1 (HIBCRIT-1) Study. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results. Invest Radiol 2011; 46 (2) 94-105
    CrossrefPubMedGoogle Scholar
  • 60 Warner E, Plewes DB, Hill KA , et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004; 292 (11) 1317-1325
    CrossrefPubMedGoogle Scholar
  • 61 Jayasinghe Y, Simmons P. Breast disorders in the female. In: Fisher M, Alderman E, Kreipe R, Rosenfeld W, , eds. AAP Textbook of Adolescent Health-Care. Elk Grove Village, IL: American Academy of Pediatrics; 2011: 621-634
    Google Scholar
  • 62 Peters NH, Borel Rinkes IH, Zuithoff NP, Mali WP, Moons KG, Peeters PH. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008; 246 (1) 116-124
    CrossrefPubMedGoogle Scholar
  • 63 Laumann AE, Derick AJ. Tattoos and body piercings in the United States: a national data set. J Am Acad Dermatol 2006; 55 (3) 413-421
    CrossrefPubMedGoogle Scholar
  • 64 Mayers LB, Chiffriller SH. Body art (body piercing and tattooing) among undergraduate university students: “then and now”. J Adolesc Health 2008; 42 (2) 201-203
    CrossrefPubMedGoogle Scholar
  • 65 Holbrook J, Minocha J, Laumann A. Body piercing: complications and prevention of health risks. Am J Clin Dermatol 2012; 13 (1) 1-17
    CrossrefPubMedGoogle Scholar
  • 66 Armstrong ML, Caliendo C, Roberts AE. Pregnancy, lactation and nipple piercings. AWHONN Lifelines 2006; 10 (3) 212-217
    CrossrefPubMedGoogle Scholar
  • 67 Modest GA, Fangman JJ. Nipple piercing and hyperprolactinemia. [letter] N Engl J Med 2002; 347 (20) 1626-1627
    CrossrefPubMedGoogle Scholar
  • 68 Jacobs VR, Golombeck K, Jonat W, Kiechle M. Mastitis nonpuerperalis after nipple piercing: time to act. Int J Fertil Womens Med 2003; 48 (5) 226-231
    PubMedGoogle Scholar
  • 69 Armstrong ML, DeBoer S, Cetta F. Infective endocarditis after body art: a review of the literature and concerns. J Adolesc Health 2008; 43 (3) 217-225
    CrossrefPubMedGoogle Scholar